Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
In 9.551101
Ġrecent 3.614895
Ġyears 0.39828038
, 0.5876466
Ġsubstantial 8.426229
Ġadvancements 5.8426757
Ġhave 0.44651008
Ġbeen 0.06793923
Ġmade 0.054131947
Ġin 0.16998558
Ġthe 0.62248635
Ġtreatment 2.669659
Ġof 0.08023779
Ġmelan 5.638247
oma 0.055768058
Ġ- 6.6716194
Ġa 1.6286608
Ġhighly 2.7783484
Ġaggressive 1.1695248
Ġform 1.1735923
Ġof 0.0012396618
Ġskin 0.1531786
Ġcancer 0.006028891
. 0.6482198
ĠImm 7.1788483
une 0.010106161
Ġcheckpoint 0.63499
Ġinhibitors 0.37599063
Ġand 4.140588
Ġadj 6.068631
u 0.073587276
vant 0.0003264598
Ġtherapies 1.1783218
Ġhave 0.6685296
Ġemerged 4.2992253
Ġas 0.092878684
Ġgroundbreaking 6.32326
Ġtreatments 1.9277631
Ġthat 2.398167
Ġoffer 4.1590605
Ġthe 3.0196426
Ġpotential 1.2218139
Ġfor 1.0181401
Ġlong 1.3498362
- 0.20177153
term 0.15804595
Ġremission 4.7002416
. 1.4443601
ĠThis 3.8323905
Ġessay 6.4750943
Ġexplores 3.4628046
Ġthe 0.40331933
Ġimplications 5.73075
Ġof 0.15456598
Ġthese 0.8542255
Ġtherapies 2.5390952
Ġfor 1.7291405
Ġpatients 2.4861038
Ġat 4.731292
Ġdifferent 2.5525036
Ġstages 0.20363513
Ġof 0.13123457
Ġmelan 1.1322803
oma 0.008349813
, 1.5867369
Ġfocusing 3.952962
Ġon 0.46404877
Ġtheir 3.0468628
Ġimpact 2.6785998
Ġon 0.15507026
Ġimproving 7.1517687
Ġsurvival 1.0325246
Ġrates 1.4958698
. 1.4772514
ĠTo 5.1148696
Ġfurther 5.179388
Ġillustrate 2.1992812
Ġthese 2.1593165
Ġadvancements 4.0911484
, 0.15758692
Ġthe 1.8991696
Ġcase 3.77251
Ġof 0.22935568
ĠMr 3.669164
. 0.55107313
ĠB 3.2797813
, 1.0767815
Ġa 0.1839541
Ġmelan 4.096531
oma 0.00019368572
Ġpatient 0.0616809
, 1.098093
Ġwill 0.73779184
Ġbe 0.03517494
Ġused 1.3948525
Ġas 1.7561424
Ġan 0.8585536
Ġexample 0.14768986
. 0.52453583
Ċ 0.5128369
Body 8.129473
: 0.032732535
Ċ 0.13417967
The 2.305391
Ġintroduction 4.6209426
Ġof 1.3547138
Ġimmune 0.6579633
Ġcheckpoint 0.031564984
Ġinhibitors 0.09550834
, 2.2134345
Ġsuch 1.1503018
Ġas 0.001050857
Ġp 3.0560937
emb 0.0013986006
rol 0.004615847
iz 0.0004994438
um 0.0031109157
ab 0.00022111216
Ġand 0.823615
Ġn 0.15406154
iv 0.0002534825
ol 0.000114638155
um 0.010123136
ab 0.0005451852
, 0.12775938
Ġmarks 5.1805773
Ġa 0.2442133
Ġsignificant 1.5520818
Ġshift 2.0146875
Ġin 0.12539475
Ġmelan 1.7271874
oma 0.00042544052
Ġtreatment 0.23170164
. 0.38239396
ĠThese 1.297256
Ġinhibitors 4.014002
Ġtarget 2.271061
Ġspecific 2.0647397
Ġcheckpoints 3.2984715
Ġon 2.7583015
Ġimmune 1.1400226
Ġcells 0.05031629
, 0.67766726
Ġeffectively 4.5570884
Ġblocking 3.9050179
Ġthe 1.0346357
Ġsignals 3.2120862
Ġthat 0.22652918
Ġprevent 1.303731
ĠT 2.542867
- 0.5843824
cells 0.10406137
Ġ( 3.9111013
a 0.6875667
Ġtype 0.2764425
Ġof 0.0010617754
Ġimmune 2.0178344
Ġcell 0.03292298
) 0.07006638
Ġfrom 0.007306242
Ġattacking 0.33949694
Ġcancer 0.52604115
Ġcells 0.42712843
. 0.1230029
ĠAs 2.5028882
Ġa 0.29221597
Ġresult 0.030635312
, 0.07496037
Ġthe 1.1065323
Ġbody 1.6477064
's 0.29690862
Ġimmune 0.57355404
Ġsystem 0.18527687
Ġis 0.39010844
Ġreact 4.0045476
ivated 0.00011285097
, 1.1707195
Ġenhancing 5.1343784
Ġits 0.6822124
Ġability 0.334506
Ġto 0.0020271959
Ġfight 1.0298043
Ġmelan 2.3627129
oma 0.031457342
. 0.5349541
ĠSeveral 5.206473
Ġstudies 1.6949635
Ġhave 0.2402916
Ġreported 3.4922652
Ġremarkable 3.5327272
Ġresponse 3.0853333
Ġrates 0.054107595
Ġto 1.377065
Ġimmune 1.9785812
Ġcheckpoint 0.007167434
Ġinhibitors 0.10658815
, 0.7792843
Ġwith 0.406295
Ġa 2.7399218
Ġsubset 3.7639792
Ġof 0.009952753
Ġpatients 0.077705875
Ġachieving 1.694871
Ġdurable 3.7105148
Ġlong 3.5933976
- 0.028657334
term 0.017140994
Ġremission 1.8503518
. 0.4400406
Ċ 1.7496817
Pat 5.711861
ients 0.07801482
Ġwith 0.59446955
Ġadvanced 1.0234087
Ġor 3.191401
Ġmetast 0.042632997
atic 0.0017122508
Ġmelan 0.4095289
oma 0.004201976
Ġhave 1.7877139
Ġparticularly 4.360048
Ġbenefited 0.28901199
Ġfrom 0.018265676
Ġimmune 1.1397247
Ġcheckpoint 0.008691502
Ġinhibitors 0.09979093
. 0.27473584
ĠResearch 6.7557187
, 6.563638
Ġincluding 0.82892007
Ġclinical 4.028253
Ġtrials 0.14633971
, 0.66451716
Ġconsistently 6.3885355
Ġdemonstrate 1.8071495
Ġimproved 2.823568
Ġoverall 1.6473974
Ġsurvival 0.12699665
Ġrates 0.69458395
Ġand 1.8027788
Ġprogression 1.5129728
- 0.100076735
free 0.0016101575
Ġsurvival 0.016181543
Ġin 2.309232
Ġpatients 1.0024127
Ġtreated 0.93994355
Ġwith 0.0072171446
Ġthese 1.3932769
Ġinhibitors 1.80262
Ġcompared 3.1349127
Ġto 0.09395945
Ġtraditional 3.4379227
Ġchemotherapy 0.45463407
. 0.48500338
ĠFor 2.0803869
Ġinstance 1.8883884
, 0.0013788439
Ġa 1.0257595
Ġstudy 1.6210845
Ġpublished 1.8159338
Ġin 0.21173711
Ġthe 0.91907996
ĠNew 0.49737242
ĠEngland 0.002251552
ĠJournal 0.0011145219
Ġof 0.0022708478
ĠMedicine 0.00069721276
Ġreported 1.8252852
Ġa 1.1778903
Ġmedian 0.8114138
Ġoverall 0.34360567
Ġsurvival 0.0011614263
Ġof 0.79107696
Ġ72 9.042219
. 0.40694895
1 1.9340277
Ġmonths 0.08420748
Ġin 0.8122391
Ġpatients 0.7369245
Ġreceiving 2.2724688
Ġp 0.96474445
emb 0.00085600157
rol 0.0076237307
iz 0.00028424585
um 0.00073055556
ab 4.2511267e-05
, 1.3497707
Ġcompared 0.34392482
Ġto 0.10036104
Ġ16 2.411111
. 0.03270728
0 4.182029
Ġmonths 0.0063847858
Ġin 0.26660746
Ġthose 1.5209153
Ġreceiving 0.4808165
Ġchemotherapy 0.8730275
. 0.39721775
ĠThis 2.9616816
Ġpresents 10.178775
Ġa 0.44633773
Ġsignificant 1.3443344
Ġadvancement 3.99887
, 2.8476899
Ġoffering 6.1472993
Ġnew 3.8988345
Ġhope 0.27186847
Ġto 0.6182234
Ġpatients 0.26300663
Ġwho 1.468985
Ġwere 2.1056874
Ġpreviously 0.12689616
Ġfaced 3.932024
Ġwith 0.0032084396
Ġlimited 2.7146757
Ġtreatment 0.11528492
Ġoptions 0.007886337
Ġand 2.4184659
Ġpoor 1.764603
Ġprog 0.5625466
nosis 1.5220451
. 0.025660906
Ċ 0.3742783
Furthermore 3.6758444
, 0.00060524285
Ġthe 1.9662982
Ġuse 2.896803
Ġof 0.0023826307
Ġimmune 0.29684076
Ġcheckpoint 0.003471878
Ġinhibitors 0.006682545
Ġas 3.480082
Ġadj 2.3433943
u 0.08150318
vant 8.0580685e-06
Ġtherapies 1.7453953
Ġin 2.293919
Ġpatients 0.91099733
Ġwith 0.27917615
Ġhigh 3.3876305
- 0.26832283
risk 0.0027318543
Ġmelan 1.4686925
oma 0.16010235
Ġwho 4.936531
Ġhave 0.23738882
Ġundergone 0.24859172
Ġsurgical 1.4598211
Ġrese 1.2473062
ction 0.009925245
Ġhas 1.2373494
Ġshown 2.0581515
Ġpromising 0.6386638
Ġresults 0.08137463
. 0.18135622
ĠAd 2.410611
ju 0.0022534633
vant 0.000536956
Ġtherapy 0.6081866
Ġis 0.93203396
Ġadministered 3.1879911
Ġafter 0.7360285
Ġcur 5.5605626
ative 0.000881118
Ġsurgery 0.43052995
Ġto 0.9433798
Ġeliminate 3.64248
Ġany 0.6099282
Ġremaining 0.42777136
Ġundet 6.9475956
ected 0.09909675
Ġcancer 0.23105451
Ġcells 0.16083324
Ġand 1.2448165
Ġreduce 1.2499827
Ġthe 0.08437251
Ġrisk 0.3566435
Ġof 0.013564772
Ġrec 0.30413526
urrence 0.0017012074
. 0.06559088
ĠFor 4.2971196
Ġinstance 2.028057
, 0.00092293863
Ġa 0.41936558
Ġtrial 3.944611
Ġinvestigating 4.231312
Ġthe 0.45100838
Ġuse 0.5038973
Ġof 0.0029780085
Ġp 0.9416228
emb 0.00036515848
rol 0.0014062395
iz 0.00026170976
um 0.0007622303
ab 7.3865966e-05
Ġas 0.61839014
Ġadj 1.2715119
u 0.0009295016
vant 4.0040345e-06
Ġtherapy 0.16451803
Ġfor 2.1109579
Ġpatients 1.1862261
Ġwith 0.22462483
Ġstage 2.2470245
ĠIII 0.37960538
Ġmelan 1.0394495
oma 0.0035780505
Ġdemonstrated 2.5035036
Ġa 0.63478816
Ġsignificantly 2.651921
Ġincreased 3.1116939
Ġrec 4.660803
urrence 9.997455e-05
- 0.02187328
free 0.0006722194
Ġsurvival 0.06971207
Ġamong 4.4745693
Ġthe 2.322913
Ġtreated 2.417038
Ġgroup 0.44117904
Ġcompared 1.4209833
Ġto 0.03666457
Ġthose 2.3364387
Ġreceiving 0.77216023
Ġplacebo 2.254775
. 0.38625264
ĠThese 2.786767
Ġfindings 1.0692335
Ġhighlight 2.5424652
Ġthe 0.14106704
Ġpotential 1.0611955
Ġfor 1.6127118
Ġimmune 0.55907714
Ġcheckpoint 0.0033835997
Ġinhibitors 0.01581161
Ġto 0.30544367
Ġprovide 3.5878446
Ġlong 1.2361248
- 0.015386171
term 0.0715933
Ġremission 3.085121
Ġand 1.854423
Ġimprove 1.6310786
Ġsurvival 1.0082666
Ġrates 0.45730507
Ġin 1.1176298
Ġearlier 7.5415487
Ġstages 0.45015973
Ġof 0.010952892
Ġmelan 0.35754722
oma 0.00031668
. 0.23922046
Ċ 0.15086861
The 2.453864
Ġimplications 5.713357
Ġof 0.0345446
Ġthese 1.3531874
Ġadvancements 1.422149
Ġare 0.92688614
Ġprofound 2.6984475
. 0.7128729
ĠPatients 3.4070792
Ġdiagnosed 3.7172415
Ġwith 0.17093667
Ġmelan 1.1264063
oma 0.0016121276
Ġat 1.8805791
Ġvarious 5.8747196
Ġstages 0.01077755
Ġnow 2.0981996
Ġhave 0.08449127
Ġaccess 1.5200386
Ġto 0.00097651675
Ġmore 2.1774406
Ġeffective 0.36074552
, 2.6440327
Ġtargeted 1.2121503
, 2.7654576
Ġand 0.03404286
Ġpersonalized 1.8355899
Ġtreatment 1.3187304
Ġoptions 0.2916043
. 0.45851564
ĠMoreover 3.790377
, 0.00037386353
Ġimmune 2.7748692
Ġcheckpoint 0.003623574
Ġinhibitors 0.02342953
Ġhave 0.8942207
Ġshown 2.9836514
Ġpotential 2.87332
Ġin 1.6476045
Ġextending 5.42038
Ġsurvival 1.2155358
Ġrates 0.6478665
Ġeven 2.316667
Ġin 1.1689931
Ġstage 3.9873343
ĠIV 0.038003244
Ġmelan 1.3823776
oma 0.004500042
, 0.8314118
Ġhistorically 6.198396
Ġthe 3.584868
Ġmost 0.16349903
Ġchallenging 2.6316133
Ġto 1.1982229
Ġtreat 0.012203977
. 0.16568726
ĠThis 2.6210086
Ġremarkable 6.3744063
Ġprogress 0.49858508
Ġnot 4.583295
Ġonly 0.00024954765
Ġprolong 6.2378187
s 0.00038316465
Ġthe 1.2383608
Ġlives 0.24585709
Ġof 0.004527164
Ġmelan 2.704435
oma 3.7863996e-05
Ġpatients 0.019285955
Ġbut 1.7600671
Ġalso 0.2130228
Ġimproves 1.1764003
Ġtheir 0.5235819
Ġquality 0.06655309
Ġof 0.003986994
Ġlife 0.0027062725
Ġby 1.783987
Ġreducing 0.875967
Ġthe 0.7722221
Ġburden 2.5808363
Ġof 0.05242222
Ġtraditional 4.5885396
Ġtreatments 2.2082496
, 1.5439334
Ġsuch 0.4787186
Ġas 0.00084228313
Ġchemotherapy 0.32676488
. 0.85084575
Ċ 0.42930216
The 2.6260755
Ġcase 0.45022228
Ġof 0.106397256
ĠMr 0.018061977
. 0.011193063
ĠB 0.0052880542
Ġexempl 4.2276363
ifies 0.0054312767
Ġthe 0.6276098
Ġtransformative 4.7104616
Ġimpact 0.72460437
Ġof 0.11848665
Ġimmune 0.3271956
Ġcheckpoint 0.0019434665
Ġinhibitors 0.014648481
Ġon 0.9796673
Ġmelan 0.639168
oma 9.7114484e-05
Ġtreatment 0.6561495
. 0.06749602
ĠMr 0.7121084
. 0.0064304965
ĠB 0.0022192926
, 2.214455
Ġdiagnosed 3.723876
Ġwith 0.06890549
Ġstage 0.31808606
ĠIV 0.5707278
Ġmelan 0.26789936
oma 9.437268e-05
Ġand 3.6053326
Ġgiven 1.6452482
Ġa 0.66369385
Ġbleak 5.793722
Ġprog 0.11804366
nosis 0.0005326626
, 0.58378893
Ġcommenced 7.672685
Ġp 2.2352133
emb 0.0017041331
rol 0.0013975269
iz 0.00017198599
um 0.0006982875
ab 1.5805701e-05
Ġtreatment 0.5928487
. 1.3796681
ĠRem 4.6341586
ark 0.061679892
ably 1.9028084e-05
, 0.0018872696
Ġhe 1.4645411
Ġexperienced 1.3082124
Ġtumor 5.088053
Ġregression 0.2906529
, 1.8394264
Ġleading 3.1794333
Ġto 0.10806578
Ġa 1.0893295
Ġcomplete 1.5688591
Ġresponse 0.9754433
Ġand 1.6662811
Ġdurable 3.2321382
Ġlong 0.74652225
- 0.0054050856
term 0.00091315503
Ġremission 0.05135879
. 0.15301773
ĠThis 1.9899557
Ġexample 4.6553745
, 3.969738
Ġamong 2.9717126
Ġcountless 4.3485713
Ġothers 0.042527568
, 0.049493928
Ġdemonstrates 1.5261403
Ġthe 0.20213698
Ġpotential 1.9884446
Ġof 0.5131221
Ġimmune 0.18609019
Ġcheckpoint 0.0029750802
Ġinhibitors 0.00864755
Ġin 1.6564759
Ġproviding 2.7290764
Ġlife 3.4191415
- 0.02030338
al 2.862824
tering 0.0021440268
Ġoutcomes 1.9247735
Ġfor 0.45182008
Ġmelan 0.9708931
oma 6.110595e-05
Ġpatients 0.004493996
. 0.14606492
Ċ 0.20346181
Conclusion 1.147317
: 0.026817806
Ċ 0.048501298
The 1.7781539
Ġadvancements 2.5015452
Ġin 0.24838449
Ġmelan 0.35635847
oma 3.023464e-05
Ġtreatment 0.049103692
Ġthrough 3.600104
Ġthe 0.39366192
Ġuse 0.3914552
Ġof 0.0027597651
Ġimmune 0.020773806
Ġcheckpoint 0.0039390004
Ġinhibitors 0.0025303357
Ġand 0.89152586
Ġadj 0.2644329
u 0.027800329
vant 1.0681599e-05
Ġtherapies 0.056319065
Ġhave 1.3749577
Ġrevolution 2.4758544
ized 0.0016171437
Ġpatient 3.1398323
Ġcare 0.8327952
. 0.43382084
ĠThese 1.4030353
Ġtherapies 1.4904726
Ġoffer 2.2622066
Ġnewfound 8.115505
Ġhope 0.13338408
Ġfor 1.0198444
Ġmelan 1.993621
oma 7.279122e-05
Ġpatients 0.007273941
Ġat 1.7022455
Ġvarious 2.1991622
Ġstages 0.01065103
, 0.7431308
Ġincluding 3.0945783
Ġthose 0.22924691
Ġwith 0.75032514
Ġadvanced 1.0953494
Ġor 0.85079336
Ġmetast 0.021907214
atic 0.00026481107
Ġdisease 0.20008692
. 0.3210533
ĠThe 2.26304
Ġcase 2.4444172
Ġof 0.04118171
ĠMr 0.0065594837
. 0.000259442
ĠB 0.00228405
Ġexempl 2.733379
ifies 0.007600486
Ġthe 0.38879618
Ġpotential 1.8275039
Ġfor 1.657661
Ġlong 3.5788872
- 0.00416223
term 0.011250206
Ġremission 0.3972016
Ġand 0.9844274
Ġimproved 0.51685125
Ġchances 9.663601
Ġof 0.11990763
Ġsurvival 0.022898948
. 2.6992886
ĠAs 2.4906478
Ġresearch 1.8487723
Ġcontinues 0.69628876
Ġto 0.5572968
Ġenhance 6.8800716
Ġour 0.36027557
Ġunderstanding 0.071006976
Ġof 0.02882265
Ġthese 2.1329114
Ġtherapies 0.9487262
, 0.2742105
Ġit 2.5021086
Ġis 0.17825575
Ġcrucial 4.376797
Ġto 0.72411066
Ġensure 2.6772237
Ġaccessibility 4.139541
, 3.887787
Ġaffordability 0.95120543
, 0.030771023
Ġand 0.0073330216
Ġexpand 10.147465
Ġtheir 1.3384646
Ġuse 0.6412948
Ġto 0.8248418
Ġfurther 4.4783273
Ġimprove 0.58748174
Ġthe 1.4893478
Ġprog 3.2580009
nosis 0.010007419
Ġand 2.5686977
Ġquality 0.34324768
Ġof 0.0029695793
Ġlife 0.014525402
Ġfor 0.86020434
Ġmelan 1.0260926
oma 4.608659e-05
Ġpatients 0.004034691
. 0.12616903
